查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1347511

發作性睡病藥物市場：2023-2028 年全球行業趨勢、佔有率、規模、成長、機遇和預測

Narcolepsy Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

市場概況：

2022年，全球發作性睡病藥物市場規模達到31億美元。展望未來，IMARC Group預計到2028年市場規模將達到48億美元，2023-2028年年複合成長率（CAGR）為7.51%。

發作性睡病藥物是指用於治療慢性睡眠障礙的藥物。該疾病的特點是白天過度嗜睡（EDS）、猝倒或肌力突然喪失、睡眠麻痺、幻覺、睡眠碎片和失眠。其他症狀可能包括無意識的自動行為、視力模糊、複視或眼瞼下垂以及精神功能紊亂。患有發作性睡病的患者每天的睡眠時間往往與正常人相同；然而，睡眠品質往往較差。一些常用的發作性睡病藥物包括中樞神經系統興奮劑、羥丁酸鈉、選擇性血清素再攝取抑製劑和三環類抗抑鬱藥。這些藥物有助於改善成年患者的清醒狀態，並最大限度地減少幻覺、嗜睡和猝倒。

發作性睡病藥物市場趨勢：

全球發作性睡病患病率的不斷上升是推動市場成長的關鍵因素之一。這可以歸因於工作人群久坐的生活方式和忙碌的日程安排，這反過來又顯著增加了與睡眠相關的疾病的發生率。此外，大眾健康意識的提高以及對可用治療替代方案的認知不斷增強，正在推動市場成長。與此相一致的是，羥丁酸鈉廣泛用於治療兒童發作性睡病也促進了市場的成長。此外，發作性睡病診斷技術的顯著改進也是其他生長誘導因素。製藥商也在開發具有長期效益和減少副作用的變體。其他因素，包括更容易患此類疾病的老年人口的增加，以及神經病學領域廣泛的研究和開發（R&D）活動，預計將推動市場成長。

本報告回答的關鍵問題：

  • 迄今為止，全球嗜睡症藥物市場表現如何，未來幾年將如何表現？
  • COVID-19 對全球發作性睡病藥物市場有何影響？
  • 主要區域市場有哪些？
  • 根據類型分類市場是怎樣的？
  • 根據疾病類型的市場分類是怎樣的？
  • 根據治療類型的市場細分是什麼？
  • 行業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球發作性睡病藥物市場的結構如何？誰是主要參與者？
  • 行業競爭程度如何？

目錄

第一章：前言

第 2 章：範圍和方法

  • 研究目的
  • 利益相關者
  • 數據源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球發作性睡病藥物市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按類型分類的市場細分

  • 發作性睡病伴猝倒
    • 市場走向
    • 市場預測
  • 不伴有猝倒的發作性睡病
    • 市場走向
    • 市場預測
  • 繼發性嗜睡症
    • 市場走向
    • 市場預測

第 7 章：按疾病類型分類的市場

  • 白天極度困倦
    • 市場走向
    • 市場預測
  • 猝倒症
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：按治療類型分類的市場細分

  • 羥丁酸鈉
    • 市場走向
    • 市場預測
  • 中樞神經系統興奮劑
    • 市場走向
    • 市場預測
  • 三環類抗抑鬱藥
    • 市場走向
    • 市場預測
  • 選擇性血清素再攝取抑製劑
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：按地區分類的市場細分

  • 北美
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳大利亞
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Avadel Pharmaceuticals plc
    • Axsome Therapeutics Inc.
    • Bioprojet Pharma
    • Graymark Healthcare Inc.
    • Jazz Pharmaceuticals plc
    • Ligand Pharmaceuticals Incorporated
    • Novartis AG
    • SHIONOGI & Co. Ltd.
    • Takeda Pharmaceutical Company Limited
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112023A5685

Market Overview:

The global narcolepsy drugs market size reached US$ 3.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.51% during 2023-2028.

Narcolepsy drugs refer to pharmaceutical medicines used for the treatment of chronic sleep disorders. The disorder is characterized by excessive daytime sleepiness (EDS), cataplexy or sudden loss of muscle strength, sleep paralysis, hallucinations, fragmented sleep and insomnia. Additional symptoms may include automatic behaviors without conscious awareness, blurred vision, double vision or droopy eyelids and disturbed mental functioning. Patients suffering from narcolepsy tend to sleep the same number of hours per day as normal individuals; however, sleep quality tends to be poorer. Some of the commonly used narcolepsy drugs include central nervous system stimulants, sodium oxybate, selective serotonin reuptake inhibitors and tricyclic antidepressants. These drugs aid in improving wakefulness in adult patients and minimizing hallucinations, sleepiness and cataplexy.

Narcolepsy Drugs Market Trends:

The increasing prevalence of narcolepsy across the globe is one of the key factors driving the growth of the market. This can be attributed to the sedentary lifestyles and hectic schedules of the working population, which, in turn, is significantly increasing the incidences of sleep-related disorders. Moreover, rising health consciousness among the masses and the increasing awareness regarding the available treatment alternatives are providing a thrust to the market growth. In line with this, the widespread adoption of sodium oxybate for the treatment of narcolepsy in children is also contributing to the growth of the market. Additionally, significant improvements in the diagnostic technologies for narcolepsy are acting as other growth-inducing factors. Pharmaceutical manufacturers are also developing variants with long-term benefits and reduced side effects. Other factors, including the rising geriatric population, which is more susceptible to such ailments, along with extensive research and development (R&D) activities in the field of neurology, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global narcolepsy drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, disease type and therapeutic type.

Breakup by Type:

Narcolepsy with Cataplexy

Narcolepsy without Cataplexy

Secondary Narcolepsy

Breakup by Disease Type:

Daytime Extreme Sleepiness

Cataplexia

Others

Breakup by Therapeutic Type:

Sodium Oxybate

Central Nervous System Stimulants

Tricyclic Antidepressants

Selective Serotonin Reuptake Inhibitor

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Avadel Pharmaceuticals plc, Axsome Therapeutics Inc., Bioprojet Pharma, Graymark Healthcare Inc., Jazz Pharmaceuticals plc, Ligand Pharmaceuticals Incorporated, Novartis AG, SHIONOGI & Co. Ltd., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd

Key Questions Answered in This Report:

  • How has the global narcolepsy drugs market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global narcolepsy drugs market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the disease type?
  • What is the breakup of the market based on the therapeutic type?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global narcolepsy drugs market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Narcolepsy Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Narcolepsy with Cataplexy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Narcolepsy without Cataplexy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Secondary Narcolepsy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Disease Type

  • 7.1 Daytime Extreme Sleepiness
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cataplexia
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Therapeutic Type

  • 8.1 Sodium Oxybate
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Central Nervous System Stimulants
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Tricyclic Antidepressants
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Selective Serotonin Reuptake Inhibitor
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Avadel Pharmaceuticals plc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Axsome Therapeutics Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Bioprojet Pharma
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Graymark Healthcare Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Jazz Pharmaceuticals plc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Ligand Pharmaceuticals Incorporated
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Novartis AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 SHIONOGI & Co. Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Takeda Pharmaceutical Company Limited
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Teva Pharmaceutical Industries Ltd.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Narcolepsy Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Narcolepsy Drugs Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Narcolepsy Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Narcolepsy Drugs Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Narcolepsy Drugs Market: Breakup by Disease Type (in %), 2022
  • Figure 6: Global: Narcolepsy Drugs Market: Breakup by Therapeutic Type (in %), 2022
  • Figure 7: Global: Narcolepsy Drugs Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Narcolepsy Drugs (Narcolepsy with Cataplexy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Narcolepsy Drugs (Narcolepsy with Cataplexy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Narcolepsy Drugs (Narcolepsy without Cataplexy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Narcolepsy Drugs (Narcolepsy without Cataplexy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Narcolepsy Drugs (Secondary Narcolepsy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Narcolepsy Drugs (Secondary Narcolepsy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Narcolepsy Drugs (Daytime Extreme Sleepiness) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Narcolepsy Drugs (Daytime Extreme Sleepiness) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Narcolepsy Drugs (Cataplexia) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Narcolepsy Drugs (Cataplexia) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Narcolepsy Drugs (Other Disease Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Narcolepsy Drugs (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Narcolepsy Drugs (Sodium Oxybate) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Narcolepsy Drugs (Sodium Oxybate) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Narcolepsy Drugs (Central Nervous System Stimulants) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Narcolepsy Drugs (Central Nervous System Stimulants) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Narcolepsy Drugs (Tricyclic Antidepressants) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Narcolepsy Drugs (Tricyclic Antidepressants) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Narcolepsy Drugs (Selective Serotonin Reuptake Inhibitor) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Narcolepsy Drugs (Selective Serotonin Reuptake Inhibitor) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Narcolepsy Drugs (Other Therapeutic Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Narcolepsy Drugs (Other Therapeutic Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: North America: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: North America: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: United States: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: United States: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Canada: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Canada: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Asia-Pacific: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Asia-Pacific: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: China: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: China: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Japan: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Japan: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: India: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: India: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: South Korea: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: South Korea: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Australia: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Australia: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Indonesia: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Indonesia: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Others: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Europe: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Europe: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Germany: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Germany: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: France: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: France: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: United Kingdom: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: United Kingdom: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Italy: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Italy: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Spain: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Spain: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Russia: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Russia: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Latin America: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Latin America: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Brazil: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Brazil: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Mexico: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Mexico: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Others: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Middle East and Africa: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Middle East and Africa: Narcolepsy Drugs Market: Breakup by Country (in %), 2022
  • Figure 78: Middle East and Africa: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Global: Narcolepsy Drugs Industry: SWOT Analysis
  • Figure 80: Global: Narcolepsy Drugs Industry: Value Chain Analysis
  • Figure 81: Global: Narcolepsy Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Narcolepsy Drugs Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Narcolepsy Drugs Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Narcolepsy Drugs Market Forecast: Breakup by Disease Type (in Million US$), 2023-2028
  • Table 4: Global: Narcolepsy Drugs Market Forecast: Breakup by Therapeutic Type (in Million US$), 2023-2028
  • Table 5: Global: Narcolepsy Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Narcolepsy Drugs Market: Competitive Structure
  • Table 7: Global: Narcolepsy Drugs Market: Key Players